Our Vision
We are building the first synthetic pharmaceutical enterprise—an AI-native operating system that thinks alongside the world's largest pharma companies, not just for them.
The Problem: Complexity vs. Cognition
Bringing a new pharmaceutical product to market costs $1–2 billion and takes a decade or longer. Fewer than 5% of drug candidates achieve regulatory approval. The industry spends over $250 billion annually on R&D, yet attrition rates remain devastating at every stage.
This isn't just a science problem—it's a complexity problem. Modern pharmaceutical enterprises have become too complex for the human mind to model alone. The number of variables exceeds cognitive capacity. This is the "Complexity Ceiling."
Traditional consulting delivers static PowerPoints obsolete on delivery. Internal AI initiatives fare no better—70% of pharma digital projects fail to deliver real outcomes.
The Solution: Synthetic Enterprise
Wilbur is not a tool. It is an enterprise cognition engine—the first scaled attempt to simulate, run, test, and refine the behavior of a pharmaceutical company in full strategic, functional, and operational fidelity.
At its core, Wilbur contains thousands of synthetic coworkers, each mapped to a defined domain role—from Global Regulatory Lead to Clinical Development VP—and governed by resume-driven execution protocols. These are not LLMs run wild, but structured agents bound by domain-specific job specs and methodological boundaries.
We don't just predict success; we identify failure. Our proprietary "Failure Fingerprint" technology highlights the specific patterns that lead to collapse, allowing leaders to navigate around them.
Cognitive Augmentation
We extend the executive's ability to foresee consequences, turning intuition into evidence-based strategy. The goal: to create a new way to think in pharma organizations—one driven not by bandwidth, but by possibility.
Synthetic Coworkers
Thousands of AI agents mapped to every enterprise function—R&D, Regulatory, Safety, Medical Affairs, HEOR, Market Access, Commercial, Portfolio Strategy, and BD & Partnerships—all working in concert.
Precision Engineering
We treat organizational design as an engineering discipline. Like a wind tunnel for aerospace, Wilbur is a testing ground to rapidly iterate and perfect organizational designs before making real-world changes.
Global Impact
By de-risking pharma R&D, we accelerate the delivery of life-saving therapies to patients worldwide. AI can cut R&D timelines by up to 50% and dramatically improve success rates.
"We are building the flight simulator for the pharmaceutical enterprise. No pilot would fly a new plane without testing it first. Why do we restructure billion-dollar companies without the same rigor?"— Founder, Wilbur Salt OS